BioSpace News Archive

Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases Volume IV: Alzheimer’s Disease Therapeutics, the fourth in a series on the innovation landscape of highly prevalent, chronic diseases.

Virgo Surgical Video Solutions, Inc., a San Francisco based digital health company, received its first patent and celebrated the 30,000th gastroenterology procedure recorded with the Virgo cloud video platform.

ADC Biotechnology (ADC Bio), together with Maven Capital Partners and Bioscience Managers, is to host a webinar through ADC Review entitled ‘Investing for the future: unlocking advanced ADC manufacturing innovation” at 16:00 UK GMT time on 15 May 2019.

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region.

Dr. Handfield is highly skilled in the use of dermoscopy, an important diagnostic tool for skin cancer detection.

When a large national employer removed cost sharing for primary care visits, medical utilization fell, as did monthly costs, driven mostly by reduced emergency department (ED) visits.

Addus HomeCare Corporation (Nasdaq: ADUS), a provider of comprehensive home care services, today announced that Dirk Allison, President and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the 2019 RBC Capital Markets Global Healthcare Conference

Oncoceutics announced today that Michael Chiarella, an industry veteran with more than 20 years’ experience at a number of large and small biotech companies, is joining the company as Vice President, Clinical Operations

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that results from a pivotal trial were published online in the Annals of Internal Medicine® journal.

Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the UBS Global Healthcare Conference on Tuesday, May 21, 2019, at 3:30 p.m. EDT.